Achaogen Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Corporate Update
Mar 15, 2016 11:00 am UTC| Business
-- Commenced Pivotal Phase 3 EPIC Study of Plazomicin in Complicated Urinary Tract Infections; Continue to Expect Top-Line Data and NDA Submission in the Second Half of 2017 -- -- Reduced Enrollment Target of Phase 3...
Westcon-Comstor Signs North American Distribution Agreement with Imperva
Mar 15, 2016 11:00 am UTC| Business
REDWOOD SHORES, Calif., March 15, 2016 -- Imperva, Inc., (NYSE:IMPV), committed to protecting business-critical data and applications in the cloud and on-premises, today announced a new, North American distribution...
Rapid Micro Biosystems Appoints Natale "Nat" Ricciardi to Board of Directors
Mar 15, 2016 11:00 am UTC| Business
LOWELL, Mass., March 15, 2016 -- Rapid Micro Biosystems, a leading provider of automated, non-destructive, rapid microbial detection, is pleased to announce the addition of Natale (Nat) Ricciardi to its Board of...
Mecox Lane Announces Extraordinary General Meeting of Shareholders
Mar 15, 2016 10:45 am UTC| Business
SHANGHAI, China, March 15, 2016 -- Mecox Lane Limited (NASDAQ:MCOX) (“Mecox Lane” or the “Company”), a multi-brand and multi-channel retailer in China specializing in health, beauty and lifestyle products, today...
Mar 15, 2016 10:45 am UTC| Business
Albany, NY, March 15, 2016 -- MarketResearchReports.biz announces the addition of a new research report, titled “Semiconductor Wireless Sensor Internet of Things (IoT): Market Shares, Strategies, and Forecasts,...
LINN Energy Announces Fourth Quarter and Full-Year 2015 Results; Announces 2016 Outlook
Mar 15, 2016 10:45 am UTC| Business
HOUSTON, March 15, 2016 -- LINN Energy, LLC (NASDAQ:LINE) (“LINN” or the “Company”) and LinnCo, LLC (NASDAQ:LNCO) (“LinnCo”) announced today financial and operating results for the fourth quarter and year ended December...
Mar 15, 2016 10:45 am UTC| Business
– Updated LOXO-101 Phase 1 Clinical Data Accepted for Oral Plenary Session Presentation at 2016 AACR Annual Meeting – – LOXO-195, Next-Generation Selective TRK Inhibitor Addressing Potential Acquired Resistance, to Enter...